What is the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD)?
The Multimodal Treatment Study of Children with ADHD (MTA) is an ongoing, multi-site, cooperative agreement treatment study of children conducted by the National Institute of Mental Health. The first major clinical trial in history to focus on a childhood mental disorder, and the largest clinical trial ever conducted by the NIMH, the MTA has examined the leading treatments for ADHD, including various forms of behavior therapy and medications. Te study has included nearly 600 elementary school children, ages 7-9, randomly assigned to one of four treatment modes: (1) medication alone; (2) psychosocial/behavioral treatment alone; (3) a combination of both; or (4) routine community care. 2. Why is this study important? ADHD is a major public health problem of great interest to many parents, teachers, and health care providers. Up-to-date information concerning the long-term safety and comparative effectiveness of its treatments is urgently needed. While previous studies have examined the s
Related Questions
- What are the natural treatment of ADHD (Attention-Deficit Hyperactivity Disorder) or ADD (Attention Deficit Disorder)?
- Do Children With Attention Deficit Hyperactivity Disorder (ADHD) Need Medication To Control Their Behavior?
- What is the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD)?
